[LABP] QoQ Quarter Result on 30-Sep-2021 [#Q3]

Stock
[LABP] Landos Biopharma, Inc.
Announcement Date
15-Nov-2021
Financial Year
2021
Quarter
30-Sep-2021 [#Q3]
Profit Trend
QoQ- -407.64%
YoY- -53.15%
Quarter Report
LABP's Result
LABP's Financial Summary
View:
Show?
Quarter Result
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
Revenue 0 0 -18,000 0 18,000 0 0 -
PBT -11,284 -14,864 -20,097 -12,604 4,097 -9,818 -11,341 -0.33%
Tax 18 -89 320 191 -174 64 -437 -
NP -11,302 -14,775 -20,097 -12,604 4,097 -9,818 -11,341 -0.23%
Tax Rate - - - - 4.25% - - -
Total Cost 11,302 14,775 2,097 12,604 13,903 9,818 11,341 -0.23%
Ratio Analysis
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
NP Margin 0.00 0.00 111.65 0.00 22.76 0.00 0.00 -
Per Share
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
EPS -2.81 -3.67 -5.20 -3.20 1.20 -3.80 -2.90 -2.08%
EPS Diluted -2.81 -3.67 -5.20 -3.20 1.20 -3.80 -2.90 -2.08%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.